Not yet recruitingPhase IInterventional

Deferred Registration: Quotient Sciences Code: QSC302324

This study is a Phase 1 clinical trial organised by Quotient Sciences, a UK research company. Phase 1 trials are the first step in testing a new potential medicine in humans. They almost always involve healthy volunteers rather than patients with specific illnesses, focusing on safety and how the body handles the medicine. The public record for this study is currently 'deferred'. In the UK, researchers can legally delay publishing scientific details for a limited time to protect early research information. However, the trial must still follow strict UK safety regulations and receive approval from an independent ethics committee. Full details about the medicine, tests, and schedule will be published on the registry once the deferral period ends. People interested in taking part can contact the research unit directly for current screening criteria.

At a glance

Status

Not yet recruiting

Phase

Phase I

Sponsor

Pheno Therapeutics Limited

Enrolment target

Start

17 Nov 2026

Estimated completion

20 Nov 2027

This is a phase I trial in healthy volunteers only and qualifies for an automatic deferral. The full details will be added to the trial record on or before the deferral expiry date

What is this study about?

When new medicines are created in a laboratory, scientists need to find out how they work in the human body before they can be given to patients. This study is a Phase 1 clinical trial, which means it is one of the very first tests of a new medicine in people. The main purpose is not to cure an illness, but to check that the treatment is safe, observe any side effects, and see how long it takes to clear from the body.

This trial is being conducted by Quotient Sciences, an organisation in the UK that specialises in early medical research. Because it is designed for healthy volunteers, researchers can see how the treatment behaves without other health conditions or daily medications interfering with the results. This vital step helps doctors decide the right dose to use in future studies.

You might notice that specific details about the medicine are not yet listed. In the UK, research rules allow companies to request a temporary delay, called a deferral, before publishing full scientific details. This is common in early-stage commercial research to protect new discoveries. It does not mean safety steps have been skipped; every study must still be reviewed by an independent Research Ethics Committee and the UK medicines regulator (MHRA) before any volunteer takes part.

Studies like this are crucial for modern healthcare. Every medicine available at your local pharmacy had to start in a Phase 1 trial with healthy volunteers. By testing safety early, researchers lay the foundation for new treatments for serious illnesses in the years ahead.

Key takeaways

This is an early-stage Phase 1 trial looking for healthy volunteers.
The study is run by Quotient Sciences in the UK to test safety and dosing.
Full scientific details are temporarily delayed on the public registry under standard rules.
The trial must still pass strict UK safety and ethics approvals before starting.
Volunteers receive thorough health checks and are free to leave the trial at any time.

Who may be eligible?

This trial is specifically looking for healthy volunteers. It is not designed to treat a disease, so people with chronic or ongoing medical conditions are usually not able to join.

Because the full registration is temporarily delayed, the exact age limits and medical criteria are not yet listed on the public register. However, Phase 1 trials generally look for adults who do not smoke, are within a healthy weight range, and are not taking regular prescription medications.

If you are interested in joining, the research team will carry out standard health checks. These usually include blood tests, heart rhythm checks (an ECG), and a review of your medical history to ensure it is safe for you to take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

I consider myself to be in good general health.
I do not have long-term or serious medical conditions.
I am not currently taking regular prescription medicines.
I am willing to undergo blood tests and medical checks.
I am able to visit or stay overnight at a UK clinical research clinic.

Answer every question to see your result.

What does participation involve?

Taking part in a Phase 1 healthy volunteer study usually involves several stages. First, you attend a screening visit where doctors check your overall health and explain the study in full detail. If you are suitable and choose to join, you will be invited to a specialist clinic. Many Phase 1 trials require an overnight or short residential stay in the research unit so doctors and nurses can closely monitor you. During your stay, you may receive the study medicine as a tablet, liquid, or injection. The team will take regular blood samples, check your blood pressure, and record heart traces to see how your body responds. After you leave the clinic, you will likely return for one or more outpatient follow-up visits to ensure you feel well. The full timeline will be confirmed by the study team during screening.

Potential risks and benefits

Healthy volunteers do not receive any direct medical benefit from the study drug, as they do not have an illness that needs treatment. However, volunteers often appreciate receiving a comprehensive health check, and trials typically offer financial compensation to cover time, travel, and inconvenience. The main risks involve potential side effects from the study medicine, which may include mild issues like headaches or nausea, though rare and serious reactions are always possible. There is also minor discomfort from blood tests. Your safety is monitored continuously by trained medical staff. Taking part is completely voluntary, and you have the right to withdraw from the trial at any point without needing to give a reason.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.

Quotient Sciences Limited
City only
Nottingham, England

Common questions

What does 'deferred registration' mean?

It means the researchers have permission from UK regulators to temporarily delay publishing full scientific details to protect new research ideas. Strict safety and ethical reviews are still completed before the trial begins.

Can I take part if I have an ongoing illness?

Most Phase 1 trials require volunteers to be in good general health without chronic medical conditions. The study team can confirm exact health requirements.

Are healthy volunteers paid for taking part?

Yes, healthy volunteer trials in the UK usually provide payments to compensate for your time, travel expenses, and any time spent staying overnight at the clinic.

Is taking part safe?

All UK clinical trials are regulated by the MHRA and checked by an ethics committee. Doses start very low, and medical staff monitor volunteers closely to handle any side effects quickly.

When will full details be released?

The full scientific title, medicine name, and detailed criteria will be added to the public register on or before the agreed deferral expiry date.

How to find out more

Clinical Trials Information

info@phenotherapeutics.com - Official trial record

Always speak to your GP or specialist before deciding to take part in a study.